These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 39526
21. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs. Bowden CR, Marchione CS. J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694 [Abstract] [Full Text] [Related]
22. Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria. Shimotori M, Kobayashi M, Chiba S. Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):240-52. PubMed ID: 2862847 [Abstract] [Full Text] [Related]
23. Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs. Jaillon P, Hecklé J, Weissenburger J, Cheymol G. J Pharmacol Exp Ther; 1980 Feb; 212(2):347-53. PubMed ID: 6101348 [No Abstract] [Full Text] [Related]
24. [Comparison of the pA2 of various beta blocking agents]. Spach MO, Miesch F, Schwartz J. Nouv Presse Med; 1975 Dec 31; 4(46 Suppl):3221-2. PubMed ID: 3766 [Abstract] [Full Text] [Related]
25. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog]. Mouillé P, Cheymol G. C R Seances Soc Biol Fil; 1973 Dec 31; 167(3):440-2. PubMed ID: 4150410 [No Abstract] [Full Text] [Related]
26. Hypotensive action of beta-blocking drugs injected into the cerebral ventricle of the rat. Wepierre J, Lindenbaum A, Porquet D, Cohen Y. Arch Int Pharmacodyn Ther; 1978 Mar 31; 232(1):158-65. PubMed ID: 27151 [Abstract] [Full Text] [Related]
27. [Beta adrenergic drugs in arterial hypertension]. Gysling E. Union Med Can; 1972 Jul 31; 101(7):1336-41. PubMed ID: 4402882 [No Abstract] [Full Text] [Related]
28. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker. Kubo K, Ikeda J, Nakamura J, Nakamizo N. Arch Int Pharmacodyn Ther; 1985 Sep 31; 277(1):140-60. PubMed ID: 2865934 [Abstract] [Full Text] [Related]
29. The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats. Day MD, Roach AG. Clin Sci Mol Med Suppl; 1975 Jun 31; 2():269s-272s. PubMed ID: 28878 [Abstract] [Full Text] [Related]
30. Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs. Nakayama K, Oshima T, Koike H. Arch Int Pharmacodyn Ther; 1981 Nov 31; 254(1):145-56. PubMed ID: 6121536 [Abstract] [Full Text] [Related]
31. Comparison of the effects of propranolol, pindolol, oxprenolol and acebutolol on atrioventricular conduction in unanaesthetized dogs. Kantelip JP, Duchene-Marullaz P, Delaigue-Fabry R, Eschalier A. Br J Clin Pharmacol; 1982 Nov 31; 13(Suppl 2):159S-166S. PubMed ID: 6125165 [Abstract] [Full Text] [Related]
32. Cardiovascular effects of beta-adrenoreceptor blocking agents after intracerebroventricular administration in conscious normotensive cats. Day MD, Roach AG. Clin Exp Pharmacol Physiol; 1974 Nov 31; 1(4):333-9. PubMed ID: 4156505 [No Abstract] [Full Text] [Related]
33. [Can blockade of presynaptic adrenergic beta receptors explain the antihypertensive effects of propranolol?]. Montastruc JL, Montastruc P. C R Seances Acad Sci D; 1979 Jul 02; 289(1-2):37-40. PubMed ID: 40705 [Abstract] [Full Text] [Related]
34. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs. Okuhira M, Nakazawa M, Kameda H, Hara K, Kawada T, Imai S. Arch Int Pharmacodyn Ther; 1993 Jul 02; 323():5-15. PubMed ID: 7902696 [Abstract] [Full Text] [Related]
36. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties. Weber MA, Stokes GS, Gain JM. J Clin Invest; 1974 Dec 02; 54(6):1413-9. PubMed ID: 4154950 [Abstract] [Full Text] [Related]
37. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent. Uchida Y, Nakamura M, Shimizu S, Shirasawa Y, Fujii M. Arch Int Pharmacodyn Ther; 1983 Mar 02; 262(1):132-49. PubMed ID: 6135395 [Abstract] [Full Text] [Related]
38. Central action of beta-adrenoceptor antagonists on blood pressure after acute administration in rats. Davy M, Midol-Monnet M, Heimburger M, Wepierre J, Cohen Y. J Pharmacol; 1986 Mar 02; 17(1):28-36. PubMed ID: 2872366 [Abstract] [Full Text] [Related]
39. Effect of intracisternal application of 6-hydroxydopamine on the antihypertensive action of propranolol in the dog. Montastruc JL, Montastruc P. Eur J Pharmacol; 1980 May 02; 63(2-3):103-16. PubMed ID: 6247163 [Abstract] [Full Text] [Related]
40. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers. Bartsch W, Dietmann K, Leinert H, Sponer G. Arzneimittelforschung; 1977 May 02; 27(5):1022-6. PubMed ID: 18157 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]